RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Talis Biomedical Stock

Talis Biomedical Market capitalization 2024

Talis Biomedical Market capitalization

8.22 M USD

Ticker

TLIS

ISIN

US87424L2079

In 2024, Talis Biomedical's market cap stood at 8.22 M USD, a -25.53% increase from the 11.03 M USD market cap in the previous year.

The Talis Biomedical Market capitalization history

YEARMarket Capitalization (undefined USD)
202313.23
202231.76
2021217.39
2020-
2019-
2018-

Talis Biomedical Aktienanalyse

What does Talis Biomedical do?

Talis Biomedical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Talis Biomedical's Market Capitalization

Talis Biomedical's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Talis Biomedical's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Talis Biomedical's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Talis Biomedical’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Talis Biomedical stock

What is the current Talis Biomedical market capitalization?

The current market capitalization of Talis Biomedical is 8.22 M USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Talis Biomedical.

How has the market capitalization of Talis Biomedical developed in recent years?

The market capitalization of Talis Biomedical has increased/decreased by -25.53% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Talis Biomedical?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Talis Biomedical?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Talis Biomedical have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Talis Biomedical pay?

Over the past 12 months, Talis Biomedical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Talis Biomedical is expected to pay a dividend of 0 USD.

What is the dividend yield of Talis Biomedical?

The current dividend yield of Talis Biomedical is .

When does Talis Biomedical pay dividends?

Talis Biomedical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Talis Biomedical?

Talis Biomedical paid dividends every year for the past 0 years.

What is the dividend of Talis Biomedical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Talis Biomedical located?

Talis Biomedical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Talis Biomedical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Talis Biomedical from 8/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/26/2024.

When did Talis Biomedical pay the last dividend?

The last dividend was paid out on 8/26/2024.

What was the dividend of Talis Biomedical in the year 2023?

In the year 2023, Talis Biomedical distributed 0 USD as dividends.

In which currency does Talis Biomedical pay out the dividend?

The dividends of Talis Biomedical are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Talis Biomedical

Our stock analysis for Talis Biomedical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Talis Biomedical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.